UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004822 |
|---|---|
| Receipt number | R000005742 |
| Scientific Title | A phase II study of first-line gefitinib for advanced and recurrent EGFR mutation positivenon-small cell lung cancerwith high-risk factors |
| Date of disclosure of the study information | 2011/01/05 |
| Last modified on | 2017/07/11 09:38:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/01/05 15:22:11 | ||
| 2 | Update | 2015/05/28 10:55:33 | Recruitment status |
|
| 3 | Update | 2017/07/11 09:32:42 | Recruitment status |
|
| 4 | Update | 2017/07/11 09:38:37 | Address Address TEL Address Address TEL TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
